Bayesian Capital Management, LP 10x Genomics, Inc. Transaction History
Bayesian Capital Management, LP
- $1.01 Billion
- Q1 2024
A detailed history of Bayesian Capital Management, LP transactions in 10x Genomics, Inc. stock. As of the latest transaction made, Bayesian Capital Management, LP holds 14,100 shares of TXG stock, worth $266,067. This represents 0.05% of its overall portfolio holdings.
Number of Shares
14,100
Previous 14,500
2.76%
Holding current value
$266,067
Previous $811,000
34.77%
% of portfolio
0.05%
Previous 0.09%
Shares
5 transactions
Others Institutions Holding TXG
# of Institutions
309Shares Held
92MCall Options Held
267KPut Options Held
62.1K-
Vanguard Group Inc Valley Forge, PA9.1MShares$172 Million0.01% of portfolio
-
Baillie Gifford & CO7.42MShares$140 Million0.22% of portfolio
-
Cathie Wood Ark Investment Management LLC | St. Petersburg, Fl6.28MShares$119 Million1.68% of portfolio
-
Black Rock Inc. New York, NY6.01MShares$113 Million0.01% of portfolio
-
Morgan Stanley New York, NY5.16MShares$97.5 Million0.02% of portfolio
About 10x Genomics, Inc.
- Ticker TXG
- Exchange NASDAQ
- Sector Healthcare
- Industry Health Information Services
- Shares Outstandng 95,046,400
- Market Cap $1.79B
- Description
- 10x Genomics, Inc., a life science technology company, develops and sells instruments, consumables, and software for analyzing biological systems in North America, Europe, the Middle East, Africa, China, and the Asia Pacific. The company provides chromium and chromium connect instruments, microfluidic chips, slides, reagents, and other consumabl...